DNA Repair Enzyme Uracil DNA Glycosylase Is Specifically Incorporated into Human Immunodeficiency Virus Type 1 Viral Particles through a Vpr-Independent Mechanism

ABSTRACT The Vpr protein, encoded by the human immunodeficiency virus type 1 (HIV-1) genome, is one of the nonstructural proteins packaged in large amounts into viral particles. We have previously reported that Vpr associates with the DNA repair enzyme uracil DNA glycosylase (UDG). In this study, we extended these observations by investigating whether UDG is incorporated into virions and whether this incorporation requires the presence of Vpr. Our results, with highly purified viruses, show that UDG is efficiently incorporated either into wild-type virions or into Vpr-deficient HIV-1 virions, indicating that Vpr is not involved in UDG packaging. Using an in vitro protein-protein binding assay, we reveal a direct interaction between the precursor form of UDG and the viral integrase (IN). Finally, we demonstrate that IN-defective viruses fail to incorporate UDG, indicating that IN is required for packaging of UDG into virions.

[1]  F. Rey,et al.  A role for human immunodeficiency virus type 1 Vpr during infection of peripheral blood mononuclear cells. , 1998, The Journal of general virology.

[2]  R. Pomerantz,et al.  Diversity of HIV-1 Vpr Interactions Involves Usage of the WXXF Motif of Host Cell Proteins* , 1998, The Journal of Biological Chemistry.

[3]  L. Arthur,et al.  Ubiquitin Is Covalently Attached to the p6GagProteins of Human Immunodeficiency Virus Type 1 and Simian Immunodeficiency Virus and to the p12Gag Protein of Moloney Murine Leukemia Virus , 1998, Journal of Virology.

[4]  G. Blobel,et al.  Viral protein R regulates nuclear import of the HIV‐1 pre‐integration complex , 1998, The EMBO journal.

[5]  P. Matarrese,et al.  The HIV-1 vpr Protein Acts as a Negative Regulator of Apoptosis in a Human Lymphoblastoid T Cell Line: Possible Implications for the Pathogenesis of AIDS , 1998, The Journal of experimental medicine.

[6]  B. Roques,et al.  The Zinc Fingers of HIV Nucleocapsid Protein NCp7 Direct Interactions with the Viral Regulatory Protein Vpr* , 1997, The Journal of Biological Chemistry.

[7]  B. Spire,et al.  Human immunodeficiency virus type 1 Vif protein binds to the Pr55Gag precursor , 1997, Journal of virology.

[8]  D. Green,et al.  HIV-1 Vpr suppresses immune activation and apoptosis through regulation of nuclear factor κB , 1997, Nature Medicine.

[9]  D. Weiner,et al.  Nuclear import, virion incorporation, and cell cycle arrest/differentiation are mediated by distinct functional domains of human immunodeficiency virus type 1 Vpr , 1997, Journal of virology.

[10]  I. Chen,et al.  Human immunodeficiency virus type 1 Vpr induces apoptosis following cell cycle arrest , 1997, Journal of virology.

[11]  F. Guiguen,et al.  dUTPase-minus caprine arthritis-encephalitis virus is attenuated for pathogenesis and accumulates G-to-A substitutions , 1997, Journal of virology.

[12]  Q. Sattentau,et al.  Cell membrane vesicles are a major contaminant of gradient-enriched human immunodeficiency virus type-1 preparations. , 1997, Virology.

[13]  L. Arthur,et al.  Microvesicles are a source of contaminating cellular proteins found in purified HIV-1 preparations. , 1997, Virology.

[14]  S. Benichou,et al.  A Sequence in the N-terminal Region of Human Uracil-DNA Glycosylase with Homology to XPA Interacts with the C-terminal Part of the 34-kDa Subunit of Replication Protein A* , 1997, The Journal of Biological Chemistry.

[15]  D. Green,et al.  HIV-1 Vpr suppresses immune activation and apoptosis through regulation of nuclear factor kappa B. , 1997, Nature medicine.

[16]  B. Spire,et al.  Human Immunodeficiency Virus Type 1 Vif Protein Binds to the Pr 55 Gag Precursor , 1997 .

[17]  F. Rey,et al.  The human immunodeficiency virus type 1 Vpr transactivator: cooperation with promoter-bound activator domains and binding to TFIIB. , 1996, Journal of molecular biology.

[18]  F. Rey,et al.  Human immunodeficiency virus type 1 Vpr protein binds to the uracil DNA glycosylase DNA repair enzyme , 1996, Journal of virology.

[19]  F. Boisvert,et al.  Mutagenic analysis of human immunodeficiency virus type 1 Vpr: role of a predicted N-terminal alpha-helical structure in Vpr nuclear localization and virion incorporation , 1995, Journal of virology.

[20]  O. Narayan,et al.  Interaction of Virion Protein Vpr of Human Immunodeficiency Virus Type 1 with Cellular Transcription Factor Sp1 and trans-Activation of Viral Long Terminal Repeat (*) , 1995, The Journal of Biological Chemistry.

[21]  Meng Chen,et al.  The human immunodeficiency virus type 1 vpr gene arrests infected T cells in the G2 + M phase of the cell cycle , 1995, Journal of virology.

[22]  G. Sutter,et al.  Non‐replicating vaccinia vector efficiently expresses bacteriophage T7 RNA polymerase , 1995, FEBS letters.

[23]  B. Moss,et al.  Replication-deficient vaccinia virus encoding bacteriophage T7 RNA polymerase for transient gene expression in mammalian cells. , 1995, Virology.

[24]  F. Mammano,et al.  The p6gag domain of human immunodeficiency virus type 1 is sufficient for the incorporation of Vpr into heterologous viral particles , 1995, Journal of virology.

[25]  M. Emerman,et al.  The human immunodeficiency virus type 1 vpr gene prevents cell proliferation during chronic infection , 1995, Journal of virology.

[26]  H. Krokan,et al.  Properties of a recombinant human uracil-DNA glycosylase from the UNG gene and evidence that UNG encodes the major uracil-DNA glycosylase. , 1995, Biochemistry.

[27]  J. Luban,et al.  Specific incorporation of cyclophilin A into HIV-1 virions , 1994, Nature.

[28]  M. Emerman,et al.  The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[29]  W. Haseltine,et al.  Requirement of the Pr55gag precursor for incorporation of the Vpr product into human immunodeficiency virus type 1 viral particles , 1994, Journal of virology.

[30]  M. Emerman,et al.  HIV-1 infection of non-dividing cells , 1994, Nature.

[31]  W. Paxton,et al.  Incorporation of Vpr into human immunodeficiency virus type 1 virions: requirement for the p6 region of gag and mutational analysis , 1993, Journal of virology.

[32]  L. Ratner,et al.  Human immunodeficiency virus type 1 viral protein R localization in infected cells and virions , 1993, Journal of virology.

[33]  M. Emerman,et al.  A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells , 1993, Nature.

[34]  J. Jiricny,et al.  The purification of a mismatch-specific thymine-DNA glycosylase from HeLa cells. , 1993, The Journal of biological chemistry.

[35]  O. Bakke,et al.  Nuclear and mitochondrial forms of human uracil-DNA glycosylase are encoded by the same gene. , 1993, Nucleic acids research.

[36]  J. L. Raina,et al.  Factors underlying spontaneous inactivation and susceptibility to neutralization of human immunodeficiency virus. , 1992, Virology.

[37]  P. Luciw,et al.  Distinct subsets of retroviruses encode dUTPase , 1992, Journal of virology.

[38]  W. Haseltine,et al.  Determination of viral proteins present in the human immunodeficiency virus type 1 preintegration complex , 1991, Journal of virology.

[39]  J. Sodroski,et al.  Identification of HIV-1 vpr product and function. , 1990, Journal of acquired immune deficiency syndromes.

[40]  H. Krokan,et al.  Molecular cloning of human uracil‐DNA glycosylase, a highly conserved DNA repair enzyme. , 1989, The EMBO journal.